CARE Ratings Ltd
NSE: CARERATING BSE: 534804
CARE Ratings is a leading credit rating agency of India. The Company provides various credit ratings that helps corporates to raise capital for their various requirements and assists the investors to form an informed investment decision based on the credit risk and their own riskreturn expectations.(Source : 202003-01 Annual Report Page No:134)
₹1,719
52W: ₹1393 — ₹1965
PE 29.6 · Book ₹327 · +426% vs bookMarket Cap₹5,166 Cr
Stock P/E29.6Price to Earnings
ROCE25%Return on Capital
ROE18.9%Return on Equity
Div. Yield1.26%Face Value ₹10
Strengths
- +Company is almost debt free.
- +Company has been maintaining a healthy dividend payout of 39.8%
Shareholding Pattern
Promoters0%
FIIs23.25%
DIIs31.38%
Public45.37%
| Category | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| FIIs | 23.37% | 24.79%▲1.4 | 24.75%▼0.0 | 23.75%▼1.0 | 24.62%▲0.9 | 23.61%▼1.0 | 23%▼0.6 | 23.25%▲0.3 |
| DIIs | 26.15% | 25.28%▼0.9 | 27.5%▲2.2 | 29.38%▲1.9 | 29.76%▲0.4 | 31.6%▲1.8 | 31.3%▼0.3 | 31.38%▲0.1 |
| Public | 50.47% | 49.92%▼0.5 | 47.74%▼2.2 | 46.87%▼0.9 | 45.61%▼1.3 | 44.79%▼0.8 | 45.7%▲0.9 | 45.37%▼0.3 |
Financial Statements
| Metric | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 67 | 75 | 65 | 102 | 79 | 91 | 76 | 114 | 90 | 108 |
| Expenses | 43 | 40 | 43 | 45 | 48 | 45 | 48 | 49 | 53 | 50 |
| Operating Profit | 24 | 35 | 22 | 57 | 30 | 46 | 27 | 65 | 37 | 58 |
| OPM % | 35% | 47% | 34% | 56% | 39% | 50% | 36% | 57% | 41% | 54% |
| Net Profit | 22 | 35 | 24 | 50 | 29 | 45 | 29 | 56 | 36 | 53 |
| EPS ₹ | 7.47 | 11.67 | 8.04 | 16.6 | 9.85 | 14.99 | 9.72 | 18.61 | 12.01 | 17.77 |
AI Insights
Revenue Trend
Mar 2026 revenue at ₹388Cr, up 15.1% YoY. OPM at 48%.
Debt Position
Borrowings at ₹16Cr. Debt-to-equity ratio: 0.02x. Healthy balance sheet.
Institutional Flow
DIIs: 31.38% (+8.21pp change). FIIs: 23.25% (+3.00pp change). Promoters hold 0%.
Margin & Efficiency
ROCE declining from 40% (Mar 2015) to 25% (Mar 2026). Working capital days: 398.
Valuation
PE 29.6x with 25% ROCE. Price is 426% above book value of ₹327. Dividend yield: 1.26%.
Recent Announcements
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 2d
- Announcement under Regulation 30 (LODR)-Newspaper Publication 2d - Newspaper Advertisement for publication of Financial Results of the Company for the quarter and year ended March 31, 2026.
- Audio Recording Of Earnings Conference Call For The Quarter And Year Ended March 31, 2026 14 May - Audio recording link shared for Q4 and FY26 earnings call held May 14, 2026.
- Corporate Action - Record Date For Final Dividend 13 May - CARE Ratings approved FY26 audited results, recommended Rs14 dividend, set July 3 AGM, granted 55,000 ESOPs.
- Grant Of Esops To Eligible Employees 13 May - FY26 audited results approved; Rs14 final dividend, 55,000 ESOPs, AGM on July 3, 2026.
- Financial Year 2025 from bse
- Financial Year 2024 from bse
- Financial Year 2023 from bse